Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7570 |
RGD peptide (GRGDNP)
RGD peptide GRGDNP(2TFA),H-甘氨酰-精氨酰-甘氨酰-天冬氨酰-天冬酰胺酰-脯氨酸-OH,RGD peptide GRGDNP |
Apoptosis; Integrin | Apoptosis; Cytoskeletal Signaling |
RGD peptide (GRGDNP) (RGD peptide GRGDNP(2TFA)) 是一种整合素-配体相互作用的抑制剂,通过激活构象变化促进细胞凋亡,从而增强 caspase-3的活化,在细胞黏附、迁移、生长和分化中发挥重要作用。 | |||
TP1311 |
RGD peptide (GRGDNP) (TFA) (114681-65-1 free base)
RGD peptide (GRGDNP) (TFA) |
||
RGD peptide (GRGDNP) (TFA) promote apoptosis through activation of conformation changes that enhance pro-caspase-3 activation and autoprocessing. | |||
T76007 |
RGD peptide (GRGDNP) (TFA)
|
||
RGD peptide (GRGDNP) TFA 作为整合素-配体之间相互作用的竞争性抑制剂,阻碍α5β1与细胞外基质(ECM)的结合,并通过激活增强pro-caspase-3的自我加工和构象变化来促进细胞凋亡。该化合物在细胞粘附、迁移、生长和分化等过程中扮演着关键角色。 | |||
T81283 |
RGD-targeted Proapoptotic Peptide
|
||
RGD-targeted Proapoptotic Peptide为一肽类化合物,其C端RGD-4C肽段(ACDCRGDCFC)能够特异性地与肿瘤新生血管的整合素结合位点优先结合。 | |||
TP1458L |
Arg-Gly-Glu-Ser acetate(93674-97-6 free base)
|
Others | Others |
Arg-Gly-Glu-Ser acetate(93674-97-6 free base) 是一种 RGD 相关肽,可控制纤维蛋白原与活化血小板结合的 RGDS 活性。 | |||
T7566L |
GRGDSPK 2TFA(111119-28-9(free base))
EMD 56574 |
Others | Others |
GRGDSPK 2TFA(111119-28-9(free base)) (EMD 56574) 是一种抑制肽,用于 RGD 介导的整合素和细胞外基质分子之间的粘附。 | |||
TP1290 |
GRGDSP acetate(91037-75-1 free base)
GRGDSP TFA |
Integrin | Cytoskeletal Signaling |
GRGDSP acetate(91037-75-1 free base) 是一种合成的线性 RGD 肽,是一种整合素抑制剂。 | |||
TP1330 |
Cyclo(RADfK)
|
Integrin | Cytoskeletal Signaling |
Cyclo(RADfK) 是选择性 α(v)β(3) 整合素配体,广泛用于新血管生成的研究、治疗和诊断。它是 cyclo (-RGDfK-) 的阴性对照, RGD 肽。 RGD 肽是细胞粘附的调节剂,并被整合素家族的几个成员识别。 | |||
TP1530L |
YRGDS Fibronectin Fragment acetate
YRGDS Fibronectin Fragment acetate(134282-68-1 free base) |
Others | Others |
YRGDS Fibronectin Fragment acetate (YRGDS Fibronectin Fragment acetate (134282-68-1 free base))(134282-68-1 free base) 是一种纤连蛋白片段乙酸酯,是一种粘附肽,对凝血酶刺激的血小板具有很强的结合亲和力。它是由序列组成的 RGD。 | |||
TP1696L |
CGGRGD acetate(1260223-44-6 free base)
|
Others | Others |
CGGRGD acetate(1260223-44-6 free base) 是一种以半胱氨酸为 n 端的 RGD 衍生物。 CGGRGD 采用固相多肽合成技术合成,在PCL 纤维表面添加氨基2-氰基苯并噻唑(2-cyanobenzothiazole)(2-cyanobenzothiazole (CBT))进行氨化。 | |||
TP1474 |
LXW7
|
Integrin | Cytoskeletal Signaling |
LXW7 是一种整合素αvβ3抑制剂,是含 Arg-Gly-Asp (RGD) 的环状肽,对αvβ3整联蛋白具有很高的结合亲和力,IC50为 0.68 μM。它可增强 VEGFR-2 磷酸化和 ERK1/2 活化,具有抗炎活性。 | |||
TP1421 |
GRGDSP
|
||
Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) is used as a soluble integrin-blocking RGD-based peptide. | |||
T24896 |
TP 9201
TP-9201,TP9201 |
||
TP 9201 is a platelet integrin alphaIIbbeta3 antagonist. It is a synthetic RGD-containing cyclic peptide. | |||
T78001 |
Arg-Gly-Glu-Ser TFA
|
||
Arg-Gly-Glu-Ser TFA,作为RGD相关多肽,调节RGDS对纤维蛋白原及活化血小板结合的抑制作用。 | |||
T24796 |
SK&F 107260
Skf107260,Skf-107260,Skf 107260 |
||
SK&F 107260 is an RGD-containing peptide. It is a potent GP IIb/IIIa antagonist and a vitronectin antagonist. | |||
T80075 |
Cyclo(Ala-Arg-Gly-Asp-Mamb)
XJ735 |
Integrin | Cytoskeletal Signaling |
Cyclo(Ala-Arg-Gly-Asp-Mamb) 是选择性的RGD肽拮抗剂,用于肺动脉高压治疗研究。 | |||
TP2148 |
LXW7 TFA (1313004-77-1 free base)
LXW7 TFA |
Integrin | Cytoskeletal Signaling |
LXW7 TFA, a cyclic peptide containing Arg-Gly-Asp (RGD), is an integrin αvβ3 inhibitor with an anti-inflammatory effect. LXW7 has a high binding affinity to αvβ3 integrin (IC50: 0.68 μM). It increases the phosphorylation of VEGFR-2 and activation of ERK1/2. | |||
TP1458 |
Arg-Gly-Glu-Ser
|
||
Arg-Gly-Glu-Ser is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets. | |||
T7566 |
GRGDSPK
EMD 56574 |
Others | Others |
GRGDSPK (EMD 56574) 是一种包含精氨酸-甘氨酸-天冬氨酸 (RGD) 的多肽,也是一种竞争性且可逆的抑制肽,可抑制整联蛋白-纤连蛋白结合,可用于整联蛋白在骨形成和吸收中作用的研究。 | |||
T82359 |
G-{d-Arg}-GDSP
|
||
G-{d-Arg}-GDSP为RGD多肽类似物,具有与整合素粘附受体结合的能力,能够抑制细胞对纤维连接蛋白的附着及破骨细胞的重吸收。 | |||
TP1489 |
Risuteganib
|
||
Risuteganib is a synthetic RGD (arginyl-glycyl-aspartic acid)-class peptide that regulates the functions of multiple integrin isoforms. | |||
T76378 |
RGD-4C
|
||
RGD-4C(ACDCRGDCFC)是一种携带Arg-Gly-Asp(RGD)序列的肽,具备与αv整合素结合的能力,用于模拟细胞外基质蛋白的整合素识别特性。作为αv整合素的配体,它能够与生物活性分子进行偶联,进而在动物模型中展现出抗肿瘤活性。 | |||
TP1530 |
YRGDS Fibronectin Fragment
|
||
This is a fibronectin fragment, an adhesion peptide that displays strong binding affinity to thrombin-stimulated platelets. It is RGD consisting of sequence. | |||
TP1696 |
CGGRGD
|
||
CGGRGD is a RGD derivative with cysteine as the n-terminal. CGGRGD was synthesized by solid phase peptide synthesis technology, and amino2-cyanobenzothiazole (2-cyanobenzothiazole) (2-cyanobenzothiazole (CBT) was added on the surface of PCL fiber for ammo | |||
TP1343 |
RGD Trifluoroacetate
|
||
RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; RGD Trifluoroacetate binds to integrins.RGD Trifluoroacetate is the most effective and most often employed pept | |||
T75765 |
GRGDSPK TFA
|
||
GRGDSPK TFA (EMD 56574 TFA) 是一种含有精氨酸-甘氨酸-天冬氨酸 (RGD) 序列的多肽。作为竞争性且可逆的抑制剂,它能够抑制整联蛋白与纤连蛋白的结合,用于探究整联蛋白在骨形成及吸收过程中的功能。 | |||
T80142 |
Cyclo(Gly-Arg-Gly-Asp-Ser-Pro)
c(GRGDSP) |
Integrin | Cytoskeletal Signaling |
Cyclo(Gly-Arg-Gly-Asp-Ser-Pro)(c(GRGDSP))为RGD 抑制肽。该化合物作为合成的α5β1整联蛋白配体,能够竞争性阻断 invasin(Inv)与Caco-2细胞表面α5β1整联蛋白的相互结合。 | |||
T76068 |
Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA
|
||
Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA 是一种环状RGD多肽, 对αvβ3有高亲和性,能干扰细胞整合素之间的相互作用。此化合物能抑制胚胎干细胞(ESC)的多潜能性基因表达,并可在体内减少mESC的致瘤潜力,因此适用于肿瘤研究领域。 | |||
T75724 |
LXW7 TFA
|
||
LXW7 TFA, 包含 Arg-Gly-Asp (RGD) 的环状肽,作为整合素αvβ3抑制剂,展示出对αvβ3整联蛋白高度的结合亲和力,其IC50值为0.68 μM。此外,LXW7 TFA 能够促进 VEGFR-2 磷酸化和 ERK1/2 激活,显示出抗炎活性。 | |||
T76255 |
Certepetide
|
||
Certepetide (CEND-1),即双功能环肽(a.k.a. iRGD),是一种具有穿透肿瘤功能的多肽。通过与α-V整联蛋白(alphav-integrins)的RGD motif相互作用,以及激活神经纤毛蛋白1(NRP-1),Certepetide能够将实体瘤微环境转化成临时的活性分子通道,从而在肿瘤中累积。该化合物在胰腺癌和其他实体瘤的研究中具有应用潜力。 | |||
T83704 |
A20FMDV2 TFA
|
||
A20FMDV2是一种由口蹄疫病毒(FMDV)血清型O的VP1衣壳蛋白上的α-螺旋RGD细胞相互作用域组成的肽,能够结合到αVβ6整合素上。该化合物在表达人αVβ6的H357舌鳞状细胞癌细胞中抑制αVβ6整合素依赖的细胞粘附(IC50 = 1.2 µM)。与111indium-DTPA耦合时,A20FMDV2(20 MBq)可结合于在乳腺癌小鼠异种移植模型中内源性表达的αVβ6整合素,用于放射成像分析。 |